HUMACYTE INC-CW27 (HUMAW:NASDAQ)
$0.01 0.001 (11.1111%)
Analysed HUMACYTE INC-CW27 (HUMAW:NASDAQ) News Sources
Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting
15-06-2026
yahoo.com
Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know
16-06-2026
yahoo.com
Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet
19-06-2026
yahoo.com
Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market
25-06-2026
yahoo.com
Humacyte (HUMA) Stock Fair Value Falls As Split Analyst Views Follow V012 Data
27-06-2026
yahoo.com
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why
30-06-2026
yahoo.com
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights
20-07-2026
yahoo.com
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know
21-07-2026
yahoo.com
Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting
27-07-2026
yahoo.com
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts
28-07-2026
yahoo.com
What is the current price of HUMACYTE INC-CW27 (HUMAW:NASDAQ)?
The current price of HUMACYTE INC-CW27 (HUMAW:NASDAQ) is $0.01.
HUMACYTE INC-CW27 (HUMAW:NASDAQ) absolute price change since previous trading day?
The absolute price change of HUMACYTE INC-CW27 (HUMAW:NASDAQ) since the previous trading day is $0.001.
HUMACYTE INC-CW27 (HUMAW:NASDAQ) percentage price change since previous trading day?
The percentage price change of HUMACYTE INC-CW27 (HUMAW:NASDAQ) since the previous trading day is 11.1111%.
What is the most recent average sentiment score for HUMACYTE INC-CW27 (HUMAW:NASDAQ)?
The most recent average sentiment score for HUMACYTE INC-CW27 (HUMAW:NASDAQ) is 43 out of 100.
What is the most recent average sentiment for HUMACYTE INC-CW27 (HUMAW:NASDAQ)?
The most recent sentiment for HUMACYTE INC-CW27 (HUMAW:NASDAQ) is .
SEC-8K** Filing Available For HUMACYTE INC-CW27 (HUMAW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.